Stolwyck,
This might be a bit of fancy but if you consider the rise in market capitalization of Genetech since it released news oF Avastin being approved by FDA (rise equals 536m shares by a rise of $13 equals about $7bill) and then equate that back to Progen with its approx 35m shares on issue, an equivalent Sp is about $200. However Genetech probably manufacture their product and enjoy all the benefits from it whereas PGL would only be recieving licence fees so they may attract say 20% of the total value. A bit more back of the envelope and this 20% would perhaps allow a SP for PGL approaching $40. Not forgetting at all that PI-88 is potentially three times better than Avastin so $40 not all that unrealistic.
- Forums
- ASX - By Stock
- $us2.25 (+36.4%) at nasdaq=a$2.91
Stolwyck,This might be a bit of fancy but if you consider the...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PGL (ASX) to my watchlist
|
|||||
Last
43.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $71.64M |
Open | High | Low | Value | Volume |
43.5¢ | 43.5¢ | 43.5¢ | $58.28K | 133.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 277628 | 43.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
44.0¢ | 107496 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 277628 | 0.435 |
2 | 100000 | 0.430 |
1 | 55597 | 0.425 |
1 | 83416 | 0.420 |
1 | 16000 | 0.415 |
Price($) | Vol. | No. |
---|---|---|
0.440 | 107496 | 3 |
0.445 | 195558 | 7 |
0.450 | 163892 | 8 |
0.470 | 1000 | 1 |
0.490 | 17809 | 1 |
Last trade - 15.25pm 25/06/2024 (20 minute delay) ? |
Featured News
PGL (ASX) Chart |